Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin.
Aug, 2018
Cheleste M. Thorpe , Anne V. Kane, Justin Chang, Albert Tai, Richard J. Vickers, and David R. Snydman
Stereospecific Synthesis of the Saccharosamine-Rhamnose-Fucose Fragment Present in Saccharomicin B
July 17, 2018
Marissa Bylsma and Clay S. Bennett
Accelerating Early Antituberculosis Drug Discovery by Creating Mycobacterial Indicator Strains That Predict Mode of Action
July, 2018
Maikel Boot, Susanna Commandeur, Amit K. Subudhi, Meriem Bahira, Trever C. Smith, II, Abdallah M. Abdallah, Mae van Gemert, Joël Lelièvre, Lluís Ballell, Bree B. Aldridge, Arnab Pain, Alexander Speer, Wilbert Bitter
Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis
June 26, 2018
Sangun Lee, Melanie Ginese, Gillian Beamer, Hillary R. Danz, Donald J. Girouard, Susan P. Chapman-Bonofiglio, Minhee Lee, Matthew A. Hulverson, Ryan Choi, Grant R. Whitman, Kayode K. Ojo, Samuel L. M. Arnold, Wesley C. Van Voorhis, Saul Tzipori
A global regulatory system links virulence and antibiotic resistance to envelope homeostasis in Acinetobacter baumannii
May 24, 2018
Edward Geisinger, Nadav J. Mortman, Germán Vargas-Cuebas, Albert K. Tai
Reagent-Controlled Synthesis of the Branched Trisaccharide Fragment of the Antibiotic Saccharomicin B
May 23, 2018
Sameh E. Soliman and Clay S. Bennett
CASSIA: An assistant for identifying clinically and statistically significant decreases in antimicrobial susceptibility
April 9, 2018
M. L. Tlachac, Elke Rundensteiner, Kerri Barton, Scott Troppy, Kirthana Beaulac, Shira Doron, Jian Zou,
Fluorescent Mycobacterium Tuberculosis Reporters: Illuminating Host-Pathogen Interactions
April 1, 2018
The pathogenesis of Mycobacterium tuberculosis (Mtb) is intrinsically linked to its intimate and enduring interaction with its host, and understanding Mtb–host interactions at a molecular level is critical to attempts to decrease the significant burden of tuberculosis disease.
Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates.
Apr, 2018
David R. Snydman, Laura A. McDermott, Nilda V. Jacobus, Kathryn Kerstein, Trudy H. Grossman, Joyce A. Sutcliffe
Infectious Diseases Physicians: Leading the Way in Antimicrobial Stewardship
February 12, 2018
Belinda Ostrowsky, Ritu Banerjee, Robert A Bonomo, Sara E Cosgrove, Lisa Davidson, Shira Doron, David N Gilbert, Amanda Jezek, John B Lynch, III, Edward J Septimus, Javeed Siddiqui, and Nicole M Iovine
- Strain diversity drives heterogeneous responses to tuberculosis combination therapyMay 15, 2026
- A New Era for Global Environmental Surveillance of Infectious DiseaseApril 30, 2026
- Restoration of daptomycin sensitivity with adjunctive cefazolin is associated with C-terminal MprF mutations in MRSA bacteremia isolatesApril 27, 2026
- An RNA-to-RNA Pipeline for Rapid Antiviral Antibody DevelopmentApril 9, 2026
- Antibiotic dose-response curves can measure antibiotic activity against Mycobacterium abscessus and Mycobacterium peregrinumApril 6, 2026